PCT Stock Chart & Stats
$214.80
$0.00(0.00%)
At close: 4:00 PM EDT
$214.80
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$214.80 - $302.03
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$22.10B
Enterprise Value$2.08K
Total Cash (Recent Filing)$224.82M
Total Debt (Recent Filing)$502.08M
Price to Earnings (P/E)―
Beta-0.86
Next Earnings
Nov 11, 2026EPS Estimate
-4.27Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.31
Shares Outstanding200,904,820
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.20
Price to Book (P/B)33.57
Price to Sales (P/S)184.37
P/FCF Ratio-8.39
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$183.08Price Target Upside-14.77% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)-21.61
Revenue Forecast (FY)$541.28M
Bulls Say, Bears Say
Bulls Say
Operational ExecutionResolving persistent reliability issues and expanding bottleneck capacity improves the foundation for sustained production. Higher demonstrated throughput, together with an early, under-budget turnaround, supports more dependable utilization and commercial scaling over the coming quarters.
Commercial TractionCustomer conversions across branded consumer applications provide evidence that PureFive is progressing beyond development into commercial adoption. Procter & Gamble production, retail shelf placement, and a broad pipeline can support recurring resin demand as qualifications convert into volume.
Financing RunwayExtending revolving-credit maturity gives the company additional time to fund operations and strategic initiatives while reducing near-term refinancing pressure. Combined with recent financing activity, this provides greater liquidity flexibility during the transition toward commercial-scale production.
Bears Say
Persistent LossesThe current revenue base is not yet covering production and operating costs, leaving profitability highly dependent on a successful ramp. Deeply negative gross profit and continued adjusted EBITDA losses could require further funding and delay durable earnings generation.
Cash BurnHeavy operating and free-cash-flow deficits reduce financial flexibility and make the business reliant on external capital while facilities scale. Unless utilization, yields, and margins improve materially, ongoing cash consumption can constrain investment and increase financing dependence.
Leverage And Execution DependenceA very thin equity cushion leaves the company sensitive to further losses, while planned international capacity requires successful financing and execution. Delays or cost increases could slow growth, raise capital needs, and intensify pressure on an already fragile capital structure.
PureCycle Technologies News
PCT FAQ
What was PureCycle Technologies’s price range in the past 12 months?
PureCycle Technologies lowest stock price was $214.80 and its highest was $302.03 in the past 12 months.
What is PureCycle Technologies’s market cap?
PureCycle Technologies’s market cap is $22.10B.
When is PureCycle Technologies’s upcoming earnings report date?
PureCycle Technologies’s upcoming earnings report date is Nov 11, 2026 which is in 61 days.
How were PureCycle Technologies’s earnings last quarter?
PureCycle Technologies released its earnings results on Aug 06, 2026. The company reported -$13.651 earnings per share for the quarter, missing the consensus estimate of -$4.948 by -$8.702.
Is PureCycle Technologies overvalued?
According to Wall Street analysts PureCycle Technologies’s price is currently Overvalued.
Does PureCycle Technologies pay dividends?
PureCycle Technologies does not currently pay dividends.
What is PureCycle Technologies’s EPS estimate?
PureCycle Technologies’s EPS estimate is -4.27.
How many shares outstanding does PureCycle Technologies have?
PureCycle Technologies has 200,904,820 shares outstanding.
What happened to PureCycle Technologies’s price movement after its last earnings report?
PureCycle Technologies reported an EPS of -$13.651 in its last earnings report, missing expectations of -$4.948. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of PureCycle Technologies?
Currently, no hedge funds are holding shares in MX:PCT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
PureCycle Technologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$183.08 (-14.77% Downside)
$183.08 (-14.77% Downside)
Blogger Sentiment
Bullish
MX:PCT Sentiment 100%
Sector Average 58%
Sector Average 58%
Insider Transactions
Bought Shares
Worth $1.7M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-53.58%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-3.82%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
PureCycle Technologies
PureCycle Technologies, Inc. focuses on manufacturing high-quality, recycled polypropylene (PP). The company employs a proprietary and licensed technology that converts discarded PP materials into an exceptionally pure, regenerated resin. Through an advanced purification process, they meticulously eliminate color, odor, and other unwanted substances from plastic waste feedstock, thereby producing a resin comparable to newly manufactured virgin plastic. Established in 2015, the company maintains its corporate headquarters in Orlando, Florida.
PCT Company Deck
PCT Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and commercial momentum: the company completed a successful turnaround, brought compounding in-house, achieved regulatory approvals (notably New Jersey), broadened commercial wins (including Procter & Gamble and a retail conversion), set production capability records, and materially strengthened liquidity via July financings. Offsetting these positives are continued large GAAP losses, negative adjusted EBITDA, higher near-term project spend, conditional regulatory approvals, and some dependence on meeting project financing and customer qualification timelines. Overall, the company appears to be transitioning from development to commercial scaling with reduced operational risk and growing demand, but it still faces meaningful financial and execution risks in the near term.View all MX:PCT earnings summariesPCT Stock 12 Month Forecast
Average Price Target
$183.08
▼(-14.77% Downside)